June-won W. Cheong
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes.
Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes.
Journal: Cancer cell international
Published: October 16, 2023
Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease.
Journal: Annals of hematology
Published: November 25, 2019
Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia.
Journal: Yonsei medical journal
Published: April 20, 2016
Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion.
Journal: Annals of laboratory medicine
Published: November 05, 2015
The modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP regimen.
Journal: Yonsei medical journal
Published: October 18, 2014
The role of radiotherapy in the management of POEMS syndrome.
Journal: Radiation oncology (London, England)
Published: August 13, 2014
Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.
Journal: British journal of haematology
Published: November 21, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026